Australia's Proteomics International Labs tumbles on delayed product launch in US

Proteomics International Laboratories

18/03/2024 24:05

** Shares of Proteomics International Laboratories  PIQ.AX 
fall as much as 25.6% to A$0.930, posting their biggest intraday
percentage decline since June 10, 2015
    ** Stock hits its lowest level since Jan. 29, 2024
    ** Medical technology co says the U.S. launch of PromarkerD,
its predictive test for diabetic kidney disease, is now delayed 
    ** About 640,000 shares change hands, compared with the
30-day average volume of 234,683
    ** Stock up 39.7% YTD, as of last close

 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))